Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/8/22 18:51 | 9/6/22 | CASI | Health | BioPrd | Biological Products, (No Diag | Huang James | MD | D | P.m | 230 | 4.13 | 0 | 56 | 18 | 372 | I | |||||||||||||||
9/2/22 19:35 | 8/31/22 | CASI | Health | BioPrd | Biological Products, (No Diag | Huang James | MD | D | P.m | 139 | 3.74 | 0 | 37 | 13 | 316 | I | |||||||||||||||
8/26/22 20:48 | 8/24/22 | CASI | Health | BioPrd | Biological Products, (No Diag | Huang James | MD | D | P.m | 167 | 3.75 | 0 | 45 | 19 | 279 | I | |||||||||||||||
8/23/22 20:19 | 8/19/22 | CASI | Health | BioPrd | Biological Products, (No Diag | Huang James | MD | D | P.m | 779 | 3.33 | 0 | 234 | 999% | 234 | I | |||||||||||||||
6/17/22 16:14 | 6/13/22 | CASI | Health | BioPrd | Biological Products, (No Diag | He Wei-Wu | MD | DOT | CB,CEO | P.m | 273 | 3.09 | 0 | 88 | 5 | 1,742 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |